Retina Institute of California

Arcadia, California 91007

0 studies enrolling now · 8 studies all time

What they study most

Age-Related Maculopathy, Choroidal Neovascularization, Diabetic Macular Edema, Diabetic Retinopathy, Genetics of Drug Metabolism, Macula Edema, Macular Degeneration, Macular Edema, Diabetic, Nonproliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Retinal Vein Occlusion

Studies at this site

• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy — Completed
• Safety and Efficacy of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration — Completed
• A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema — Stopped early
• Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration — Stopped early
• Utility of PharmacoGenomics for Reducing Adverse Drug Effects — Status unconfirmed
• PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) — Completed